Medtronic wins CE mark for Stealth AXiS surgical robot platform

Medtronic (NYSE:MDT) announced today that it received CE mark approval for its Stealth AXiS surgical robot platform.

Approval in Europe covers spine and cranial procedures for the planning, navigation and robotics platform. It follows back-to-back FDA nods for Stealth AXiS to kick off 2026, first garnering clearance for spine surgery, then getting the green light for cranial and ENT procedures. Medtronic also has a partnership with GE HealthCare to integrate the platform with intraoperative ultrasound technology.

A spine center in Virginia said it became the first in the world to perform surgery using Stealth AXiS last week.

Sign up for Blog Updates